Cipher Pharmaceuticals Inc. (CPH.TO)
- CNW Group
Cipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFO
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced the appointment of senior finance executive Bryan Jacobs as Chief Financial Officer ("CFO") effective August 15, 2022.
- CNW Group
Cipher Pharmaceuticals Reports Second Quarter 2022 Financial Results
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced its financial and operating results for the three and six month periods ended June 30, 2022. Unless otherwise noted, all figures are in U.S. dollars.
- CNW Group
Cipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference Call
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its Q2 2022 financial results on Thursday, August 11, 2022 after market close. The Company will also host a conference call on Friday, August 12, 2022 at 8:30am ET to discuss the results and corporate developments.
